June Social Media Round-Up—2025 Impact Report, ADA 2026, and More
School is out for the summer, but Pfizer colleagues are still hard at work. In June, we released our 2025 Impact Report, shared risks of fake medicines on World Anti-Counterfeit Day, and raised awareness of menstrual-related migraine and more.
Pfizer has also been present at many conferences this past month—from ASCO and ADA to EHA and AHS 2026, and our leadership team has been highlighting the latest data that we’ve shared at these events. Meanwhile, CEO Albert Bourla joined the CNBC CEO Council Summit to discuss Pfizer’s commitment to fighting cancer. He also highlighted our ambitions for the future of obesity treatment.
Explore these updates and more:
Executive Leadership
- CEO Albert Bourla joins the CNBC CEO Council Summit to discuss Pfizer’s commitment to fighting cancer
- Chief Scientific Officer Chris Boshoff announces Pfizer’s strategic collaboration with Innovent to accelerate development of oncology medicines
- Chief People Experience Officer Payal Sahni Becher highlights Pfizer’s recent global broadcast about becoming an AI-fluent organization
- Chief Scientific Officer Chris Boshoff announces the start of two new studies that are advancing Pfizer’s obesity pipeline
- Chief U.S. Commercial Officer Aamir Malik proudly shares findings from a real-world study evaluating effectiveness of maternal vaccination against severe RSV in infants
- Chief Scientific Officer Chris Boshoff shares his thoughts on the possibilities of innovation coming out of ASCO 2026
- CEO Albert Bourla highlights Pfizer’s ambitions for obesity treatment and the new data we shared at ADA
- Chief Scientific Officer Chris Boshoff highlights Pfizer’s presentations at AHS 2026 and our commitment to the migraine community
- CEO Albert Bourla meets with this year’s Scripps National Spelling Bee winner, Shrey
Pfizer on LinkedIn
- Pfizer publishes its 2025 Impact Report, illustrating how responsible business growth is helping shape the future of our company and the impact we strive to make
- Pfizer raises awareness of menstrual-related migraine and shares insights into menstrual-related migraine attacks
- Pfizer’s Accord for Healthier World recently connected partners and experts at WHA to explore how collaboration, local leadership, and innovative partnerships can help address barriers that continue to limit access to care
- Pfizer shines a spotlight on the threats of fake medicines on World Anti-Counterfeit Day
- Pfizer recognizes the Vitiligo community on World Vitiligo Day
Pfizer on Instagram
- Pfizer teams are working to help prevent disease caused by C. difficile infection (CDI)
- Pfizer scientists share what helps them stay focused
Pfizer on X
Pfizer on TikTok
